Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

CVS Health Corporation (NYSE:CVS) is a vertically integrated healthcare corporation in the United States. The company owns a leading healthcare benefits ... CVS). Over the past six decades ...

The company operates under three segments namely Health Care Benefits ... plans by an average of 4.3%, or over $21 billion, in 2026 compared to this year. CVS Health Corporation (NYSE:CVS ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The health-care sector has been rebounding recently following a sharp selloff in recent weeks amid hopes that controversy would die down. The health-care industry group was among the leading S&P 500 ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...

CVS, Elevance Health and Humana decline as investors react to market. What To Know: UnitedHealth, the largest health insurer in the U.S., reported a revenue increase of 6.8% year-over-year to $100 ...